In this study, FGF2 mRNA was downregulated in DCIS and invasive breast cancer tumors compared with normal breast tissues but upregulated in blood samples from DCIS and invasive breast cancer patients versus healthy individuals. The gene discussed is FGF2; the disease is invasive breast carcinoma.